Oxidative stress in renal transplant recipients with chronic rejection: rationale for antioxidant supplementation

Transplant Proc. 1999 Feb-Mar;31(1-2):1310-1. doi: 10.1016/s0041-1345(98)02010-7.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Antioxidants / therapeutic use*
  • Apolipoprotein A-I / blood
  • Apolipoproteins B / blood
  • Cholesterol / blood
  • Chronic Disease
  • Dietary Supplements
  • Female
  • Follow-Up Studies
  • Graft Rejection / physiopathology*
  • Graft Rejection / prevention & control*
  • Humans
  • Kidney Transplantation / immunology
  • Kidney Transplantation / physiology*
  • Lipid Peroxidation
  • Male
  • Malondialdehyde / blood
  • Oxidative Stress*
  • Time Factors
  • Triglycerides / blood
  • Vitamin E / therapeutic use*

Substances

  • Antioxidants
  • Apolipoprotein A-I
  • Apolipoproteins B
  • Triglycerides
  • Vitamin E
  • Malondialdehyde
  • Cholesterol